DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$56.1B
This Quarter Return
+4.1%
1 Year Return
+19.33%
3 Year Return
+93.16%
5 Year Return
+155.59%
10 Year Return
+349.91%
AUM
$55.6B
AUM Growth
+$55.6B
(+3.5%)
Cap. Flow
+$2.54B
Cap. Flow
% of AUM
4.57%
Top 10 Holdings %
Top 10 Hldgs %
29.69%
Holding
1,521
New
84
Increased
540
Reduced
453
Closed
72
Top Buys
| 1 |
NVIDIA
NVDA
|
$1.77B |
| 2 |
Apple
AAPL
|
$206M |
| 3 |
Amazon
AMZN
|
$114M |
| 4 |
Home Depot
HD
|
$97.7M |
| 5 |
Canadian Natural Resources
CNQ
|
$80.5M |
Top Sells
| 1 |
Sysco
SYY
|
$78.5M |
| 2 |
CVS Health
CVS
|
$77.8M |
| 3 |
Ball Corp
BALL
|
$56.8M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
$51M |
| 5 |
Citigroup
C
|
$50M |
Sector Composition
| 1 | Technology | 31.44% |
| 2 | Healthcare | 15.78% |
| 3 | Financials | 9.7% |
| 4 | Consumer Discretionary | 9.52% |
| 5 | Industrials | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Vertex Pharmaceuticals
VRTX
$100B
| $237M | 0.43% | 501,509 +10,380 | +2% | +$4.91M |
|
52
ConocoPhillips
COP
$124B
| $236M | 0.42% | 2,051,781 +211,746 | +12% | +$24.4M |
|
53
TSMC
TSM
$1.2T
| $230M | 0.41% | 1,318,340 -21,139 | -2% | -$3.69M |
|
54
Xylem
XYL
$34.5B
| $227M | 0.41% | 1,665,090 +36,601 | +2% | +$5M |
|
55
Regeneron Pharmaceuticals
REGN
$61.5B
| $224M | 0.4% | 213,824 -7,352 | -3% | -$7.7M |
|
56
Analog Devices
ADI
$124B
| $224M | 0.4% | 977,869 -28,561 | -3% | -$6.53M |
|
57
Blackrock
BLK
$175B
| $222M | 0.4% | 283,727 +17,348 | +7% | +$13.6M |
|
58
Amgen
AMGN
$155B
| $221M | 0.4% | 703,638 -64,305 | -8% | -$20.2M |
|
59
Republic Services
RSG
$73B
| $218M | 0.39% | 1,121,031 +8,368 | +0.8% | +$1.63M |
|
60
Intuit
INTU
$186B
| $216M | 0.39% | 331,617 +17,302 | +6% | +$11.3M |
|
61
IBM
IBM
$227B
| $215M | 0.39% | 1,252,937 -102,499 | -8% | -$17.6M |
|
62
Exxon Mobil
XOM
$487B
| $210M | 0.38% | 1,804,923 -360,296 | -17% | -$41.8M |
|
63
Eaton
ETN
$136B
| $206M | 0.37% | 655,506 -48,852 | -7% | -$15.3M |
|
64
Pfizer
PFE
$141B
| $205M | 0.37% | 7,314,809 -64,811 | -0.9% | -$1.81M |
|
65
Gilead Sciences
GILD
$140B
| $196M | 0.35% | 2,834,364 +776,785 | +38% | +$53.6M |
|
66
Walmart
WMT
$774B
| $188M | 0.34% | 2,756,019 +104,573 | +4% | +$7.13M |
|
67
Elevance Health
ELV
$71.8B
| $185M | 0.33% | 344,186 -11,783 | -3% | -$6.32M |
|
68
Applied Materials
AMAT
$128B
| $184M | 0.33% | 785,405 -5,625 | -0.7% | -$1.32M |
|
69
Sempra
SRE
$53.9B
| $182M | 0.33% | 2,404,573 +48,592 | +2% | +$3.68M |
|
70
Medtronic
MDT
$119B
| $182M | 0.33% | 2,306,104 -169,822 | -7% | -$13.4M |
|
71
Oracle
ORCL
$635B
| $179M | 0.32% | 1,274,805 -51,725 | -4% | -$7.28M |
|
72
Bristol-Myers Squibb
BMY
$96B
| $177M | 0.32% | 4,236,531 +342,143 | +9% | +$14.3M |
|
73
Danaher
DHR
$147B
| $174M | 0.31% | 689,291 -21,345 | -3% | -$5.38M |
|
74
CrowdStrike
CRWD
$106B
| $171M | 0.31% | 437,002 +19,686 | +5% | +$7.69M |
|
|
ANSS
75
DELISTED
Ansys
ANSS
| $168M | 0.3% | 522,613 +22,836 | +5% | +$7.34M |
|